Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06713473 · ClinicalTrials.gov registry record · NA
Reducing Self-Dehumanization to Examine Oxytocin and Suicide Risk
A NA study, sponsored by Florida State University.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06713473: Clinical Trial NA study, sponsored by Florida State University.
NCT06713473 is a NA study that has not yet begun recruiting, run by Florida State University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06713473, a NA study, has not yet begun recruiting, sponsored by Florida State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this experiment is to further determine if self-dehumanization is a novel risk factor for suicide. This study will reduce self-dehumanization using a novel re-humanization condition and compare this group to a control group to analyze the pathway between higher perceptions of self-dehumanization, suicidal ideation, and changes in oxytocin concentrations. It is hypothesized that participants randomly assigned to the re-humanized condition will exhibit decreases in suicidal ideation and increases in oxytocin concentrations as compared to the control condition, which will not display significant changes. Further, we will explore if the magnitude of the oxytocin response will partially mediate the change in suicidal ideation.
Primary Outcome
Suicidal Ideation will be measured using the Depressive Symptom Index-Suicidality Subscale (DSI-SS) where the scores range from 0-12 and higher scores indicate higher levels of suicidal ideation. These analyses will control for Baseline suicidal ideation and the thwarted belongingness sub-scale from the Interpersonal Needs Questionnaire where thwarted belongingness scores range from 1-56 and higher scores indicate greater perceptions of thwarted belongingness.
Interventions
- OTHER Blood Draw
- OTHER Control Intervention
- DIAGNOSTIC_TEST Clinical Interview
- OTHER Rehumanized Intervention
- OTHER Self-Report Measures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-08 |
| Est. Completion | 2028-08 |
| Phase | NA |
What is known before NCT06713473 opens enrollment
NCT06713473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Blood Draw is the first listed.
NCT06713473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06713473 about?
NCT06713473 is a clinical study titled "Reducing Self-Dehumanization to Examine Oxytocin and Suicide Risk". The goal of this experiment is to further determine if self-dehumanization is a novel risk factor for suicide. This study will reduce self-dehumanization using a novel re-humanization condition and compare this group to a control group to analyze the pathway between higher perceptions of self-dehuma...
What is the current status of trial NCT06713473?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-08. Estimated completion is 2028-08.
What interventions are being tested in trial NCT06713473?
The interventions under investigation include: Blood Draw (OTHER), Control Intervention (OTHER), Clinical Interview (DIAGNOSTIC_TEST), Rehumanized Intervention (OTHER), Self-Report Measures (OTHER).
Who is sponsoring clinical trial NCT06713473?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06713473's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia